Luthra Ankur, Bajaj Ritika, Jafra Anudeep, Jangra Kiran, Arya V K
Department of Anaesthesia and Intensive Care, Nehru Hospital, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Department of Obstetrics and Gynaecology, Jindal IVF and Sant Memorial Nursing Home, Sector 20, Chandigarh, India.
Saudi J Anaesth. 2017 Oct-Dec;11(4):454-471. doi: 10.4103/sja.SJA_277_17.
Management of pregnant women with heart disease remains challenging due to the advancement of innovations in cardiac surgery and correction of complex cardiac anomalies, and more recently, with the successful performance of heart transplants, cardiac diseases are not only likely to coexist with pregnancy, but will also increase in frequency over the years to come. In developing countries with a higher prevalence of rheumatic fever, cardiac disease may complicate as many as 5.9% of pregnancies with a high incidence of maternal death. Since many of these deaths occur during or immediately following parturition, heart disease is of special importance to the anesthesiologist. This importance arises from the fact that drugs used for preventing or relieving pain during labor and delivery exert a major influence - for better or for worse - on the prognosis of the mother and newborn. Properly administered anesthesia and analgesia can contribute to the reduction of maternal and neonatal mortality and morbidity.
由于心脏外科手术创新的进步以及复杂心脏畸形的矫正,患有心脏病的孕妇的管理仍然具有挑战性。最近,随着心脏移植手术的成功开展,心脏病不仅可能与妊娠并存,而且在未来几年其发病率还会上升。在风湿热患病率较高的发展中国家,心脏病可能使多达5.9%的妊娠复杂化,孕产妇死亡率很高。由于这些死亡许多发生在分娩期间或分娩后不久,心脏病对麻醉医生尤为重要。这种重要性源于这样一个事实,即用于预防或减轻分娩期间疼痛的药物对母亲和新生儿的预后有着重大影响,无论是好是坏。正确实施麻醉和镇痛有助于降低孕产妇和新生儿的死亡率及发病率。